NORTREL 7/7/7 Drug Patent Profile
✉ Email this page to a colleague
When do Nortrel 7/7/7 patents expire, and when can generic versions of Nortrel 7/7/7 launch?
Nortrel 7/7/7 is a drug marketed by Barr and is included in one NDA.
The generic ingredient in NORTREL 7/7/7 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for NORTREL 7/7/7
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 166 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORTREL 7/7/7 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NORTREL 7/7/7
US Patents and Regulatory Information for NORTREL 7/7/7
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | NORTREL 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 075478-001 | Aug 30, 2002 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Barr | NORTREL 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 075478-002 | Aug 30, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |